Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination Response Modulation With a Targeted Rapamycin Protocol (VON TRAPP) Study

NCT07587801 is registered in ClinicalTrials.gov with Central Adelaide Local Health Network Incorporated as lead sponsor.

NCT NCT07587801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07587801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination Response Modulation With a Targeted Rapamycin Protocol (VON TRAPP) Study
Lead sponsor
Central Adelaide Local Health Network Incorporated
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
July 31, 2026
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

haemodialysis patients, older adults, vaccine immune response